Simultaneous endovascular therapy of coronary and renal artery narrowing: safety and acute efficacy

Ruiyan ZHANG,Zhengbin ZHU,Qi ZHANG,Zhenkun YANG,Jian HU,Jionsheng ZHANG,Weifeng SHEN
2009-01-01
Abstract:Objective To retrospectively analyze the safety and acute efficacy of simultaneous endovascular therapy for both coronary and renal artery narrowing. Methods Patients confirmed with both coronary and renal artery narrowing by angiography underwent renal artery stenting immediately, within 7 days or 7 days after coronary intervention while taking into consideration of the baseline renal function and contrast volume. Results The 102 patients had 148 coronary and 113 renal narrowing sites, and all successfully underwent stent-based endovascular therapy. During 30 days' follow-up, there were no major adverse cardiovascular events, except that one patient suffered myocardial infarction due to clopedogrel cessation. Sixty-five cases with hypertension history; the blood pressure recovered to normal level in 7 (10.7%) cases and improved in 11 (16.9 %) cases; and the remaining 47 (72.3 %) cases had no obvious changes. Serum creatinine levels were similar in 21 cases with renal dysfunction before and after procedures([158±57]μmol/L vs. [142±71]μmol/L, P>0.05). Conclusion Simultaneous endovascular therapy in patients with both coronary and renal artery narrowing is safe and effective.
What problem does this paper attempt to address?